Cargando…

Treatment strategies for the right heart in pulmonary hypertension

The function of the right ventricle (RV) determines the prognosis of patients with pulmonary hypertension. While much progress has been made in the treatment of pulmonary hypertension, therapies for the RV are less well established. In this review of treatment strategies for the RV, first we focus o...

Descripción completa

Detalles Bibliográficos
Autores principales: Westerhof, Berend E., Saouti, Nabil, van der Laarse, Willem J., Westerhof, Nico, Vonk Noordegraaf, Anton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852547/
https://www.ncbi.nlm.nih.gov/pubmed/28957540
http://dx.doi.org/10.1093/cvr/cvx148
_version_ 1783306590699388928
author Westerhof, Berend E.
Saouti, Nabil
van der Laarse, Willem J.
Westerhof, Nico
Vonk Noordegraaf, Anton
author_facet Westerhof, Berend E.
Saouti, Nabil
van der Laarse, Willem J.
Westerhof, Nico
Vonk Noordegraaf, Anton
author_sort Westerhof, Berend E.
collection PubMed
description The function of the right ventricle (RV) determines the prognosis of patients with pulmonary hypertension. While much progress has been made in the treatment of pulmonary hypertension, therapies for the RV are less well established. In this review of treatment strategies for the RV, first we focus on ways to reduce wall stress since this is the main determinant of changes to the ventricle. Secondly, we discuss treatment strategies targeting the detrimental consequences of increased RV wall stress. To reduce wall stress, afterload reduction is the essential. Additionally, preload to the ventricle can be reduced by diuretics, by atrial septostomy, and potentially by mechanical ventricular support. Secondary to ventricular wall stress, left-to-right asynchrony, altered myocardial energy metabolism, and neurohumoral activation will occur. These may be targeted by optimising RV contraction with pacing, by iron supplement, by angiogenesis and improving mitochondrial function, and by neurohumoral modulation, respectively. We conclude that several treatment strategies for the right heart are available; however, evidence is still limited and further research is needed before clinical application can be recommended.
format Online
Article
Text
id pubmed-5852547
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-58525472018-03-23 Treatment strategies for the right heart in pulmonary hypertension Westerhof, Berend E. Saouti, Nabil van der Laarse, Willem J. Westerhof, Nico Vonk Noordegraaf, Anton Cardiovasc Res Invited Spotlight Reviews The function of the right ventricle (RV) determines the prognosis of patients with pulmonary hypertension. While much progress has been made in the treatment of pulmonary hypertension, therapies for the RV are less well established. In this review of treatment strategies for the RV, first we focus on ways to reduce wall stress since this is the main determinant of changes to the ventricle. Secondly, we discuss treatment strategies targeting the detrimental consequences of increased RV wall stress. To reduce wall stress, afterload reduction is the essential. Additionally, preload to the ventricle can be reduced by diuretics, by atrial septostomy, and potentially by mechanical ventricular support. Secondary to ventricular wall stress, left-to-right asynchrony, altered myocardial energy metabolism, and neurohumoral activation will occur. These may be targeted by optimising RV contraction with pacing, by iron supplement, by angiogenesis and improving mitochondrial function, and by neurohumoral modulation, respectively. We conclude that several treatment strategies for the right heart are available; however, evidence is still limited and further research is needed before clinical application can be recommended. Oxford University Press 2017-10 2017-09-05 /pmc/articles/PMC5852547/ /pubmed/28957540 http://dx.doi.org/10.1093/cvr/cvx148 Text en © The Author 2017. Published on behalf of the European Society of Cardiology http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Invited Spotlight Reviews
Westerhof, Berend E.
Saouti, Nabil
van der Laarse, Willem J.
Westerhof, Nico
Vonk Noordegraaf, Anton
Treatment strategies for the right heart in pulmonary hypertension
title Treatment strategies for the right heart in pulmonary hypertension
title_full Treatment strategies for the right heart in pulmonary hypertension
title_fullStr Treatment strategies for the right heart in pulmonary hypertension
title_full_unstemmed Treatment strategies for the right heart in pulmonary hypertension
title_short Treatment strategies for the right heart in pulmonary hypertension
title_sort treatment strategies for the right heart in pulmonary hypertension
topic Invited Spotlight Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852547/
https://www.ncbi.nlm.nih.gov/pubmed/28957540
http://dx.doi.org/10.1093/cvr/cvx148
work_keys_str_mv AT westerhofberende treatmentstrategiesfortherightheartinpulmonaryhypertension
AT saoutinabil treatmentstrategiesfortherightheartinpulmonaryhypertension
AT vanderlaarsewillemj treatmentstrategiesfortherightheartinpulmonaryhypertension
AT westerhofnico treatmentstrategiesfortherightheartinpulmonaryhypertension
AT vonknoordegraafanton treatmentstrategiesfortherightheartinpulmonaryhypertension